PW Nova Financial Services
ELDN icon

PW Nova Financial Services’s Eledon Pharmaceuticals ELDN Stock Holding History

PW Nova Financial Services’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$147K Hold
58,041
– – 0.03% 199
2026
Q2 		$229K Hold
58,041
– – 0.05% 191
2026
Q1 		$179K Hold
58,041
– – 0.04% 188
2025
Q4 		$94K Buy
+58,041
New +$138K 0.04% 110

Other funds holding ELDN

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Triumph Capital Management
Triumph Capital Management Denver, Colorado $573M AUM 15.32% 1-Year Est. Return
Daytona Street Capital
Daytona Street Capital Saint Louis, Missouri $141M AUM 14.38% 1-Year Est. Return
Prodigy Asset Management
Prodigy Asset Management Omaha, Nebraska $335M AUM 5.94% 1-Year Est. Return
Farmers & Merchants Investments Inc
Farmers & Merchants Investments Inc Lincoln, Nebraska $4.16B AUM 24.97% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
RPGK
Retirement Planning Group (Kansas) Leawood, Kansas $4.01B AUM 11.74% 1-Year Est. Return
Howard Financial Services
Howard Financial Services Dallas, Texas $954M AUM 13.71% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

PW Nova Financial Services's ELDN Position: Q3 2026 in Review

PW Nova Financial Services held its Eledon Pharmaceuticals (ELDN) position steady in Q3 2026 at 58,041 shares worth $147K. The position accounts for 0.03% of the portfolio, ranked #199.

PW Nova Financial Services first reported a position in ELDN in Q4 2025 and has held it in 4 quarters since. The position peaked at $229K in Q2 2026. 50 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.

  • PW Nova Financial Services held 58,041 shares of Eledon Pharmaceuticals worth $147K as of Q3 2026.
  • PW Nova Financial Services left its Eledon Pharmaceuticals share count unchanged in Q3 2026.
  • Eledon Pharmaceuticals made up 0.03% of PW Nova Financial Services's portfolio in Q3 2026, its #199 holding.
  • PW Nova Financial Services first reported a position in Eledon Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • PW Nova Financial Services's Eledon Pharmaceuticals position peaked at $229K in Q2 2026.
  • 50 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.

Based on PW Nova Financial Services's 13F filing for Q3 2026, filed 15 Oct 2026.